I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 5 310 KRW Market Closed
Market Cap: 210.8B KRW

Isu Abxis Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Isu Abxis Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
I
Isu Abxis Co Ltd
KOSDAQ:086890
Operating Income
â‚©14.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
â‚©889.7B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
15%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
â‚©169.2B
CAGR 3-Years
43%
CAGR 5-Years
50%
CAGR 10-Years
28%
Alteogen Inc
KOSDAQ:196170
Operating Income
â‚©75.5B
CAGR 3-Years
N/A
CAGR 5-Years
59%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Operating Income
-â‚©22.1B
CAGR 3-Years
23%
CAGR 5-Years
7%
CAGR 10-Years
N/A
D
DND PharmaTech Inc
KOSDAQ:347850
Operating Income
-â‚©25B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Isu Abxis Co Ltd
Glance View

Market Cap
196.8B KRW
Industry
Biotechnology

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Intrinsic Value
6 480.38 KRW
Undervaluation 18%
Intrinsic Value
Price
I

See Also

What is Isu Abxis Co Ltd's Operating Income?
Operating Income
14.3B KRW

Based on the financial report for Jun 30, 2025, Isu Abxis Co Ltd's Operating Income amounts to 14.3B KRW.

What is Isu Abxis Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
-1%

Over the last year, the Operating Income growth was -1%.

Back to Top